Patent details
LUC00122 Product Name: everolimus ou un sel pharmaceutiquement acceptable de celui-ci
Basic Information
- Publication number:
- LUC00122
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP161860416
- Legal Status:
- Lapsed
- Application number:
- LUC00122
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/09/538/001, 003, 004, 006-010
- Marketing Authorization Type:
- Marketing Authorization Date:
- 30/05/2016
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 04/06/2019
- First Marketing Authorization date:
- 30/05/2016
- Grant date:
- 24/12/2019
- Activation date:
- 18/02/2022
- Publication date:
- 06/06/2019
- Lapsed date:
- 18/02/2022
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 18/02/2027
- SPC Extension Expiration:
- 18/02/2027
- Rejection date:
- Withdrawal date:
Owner
- From:
- 10/06/2020
- Name:
- NOVARTIS PHARMA AG
- Address:
- Forum 1 Novartis Campus, 4056, Basel, Switzerland (CH)
History of Owners
- From:
- 04/06/2019
- To:
- 10/06/2020
- Name:
- NOVARTIS INTERNATIONAL PHARMACEUTICAL AG
- Address:
- Lichtstrasse 35, 4056, Basel, Switzerland (CH)
- Name:
- NOVARTIS PHARMA AG
- Address:
- Lichtstrasse 35, 4056, Basel, Switzerland (CH)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 04/06/2019
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2019/08
- Publication date:
- 10/07/2019
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2020/01
- Publication date:
- 13/01/2020
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
3
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2020/08
- Publication date:
- 13/07/2020
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
4
- Bulletin Heading:
- SPC3
- Bulletin edition number:
- 2022/04
- Publication date:
- 04/03/2022
- Description:
- Section E : Supplementary Protection certificates entered into force – IA publication
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20200000167A
- Date Registered:
- 10/06/2020
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- OFFICE FREYLINGER S.A.
- Journal Edition Number:
- Text:
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- NOVARTIS PHARMA AG
- Address:
- Forum 1 Novartis Campus, 4056, Basel, Switzerland (CH)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 24/12/2019 | Certificate | 1 |
| 04/06/2019 | Application Form | 4 |
| 06/06/2019 | Publication | 1 |
| 15/06/2020 | Outgoing Correspondence | 2 |
| 19/06/2019 | Incoming Correspondence (Post) | 4 |
| 06/06/2019 | Outgoing Correspondence | 1 |
| 10/06/2020 | Request For Change | 12 |
| 24/12/2019 | Publication | 1 |
| 04/06/2019 | General Document | 2 |
| 04/06/2019 | General Document | 3 |
| 19/06/2019 | Outgoing Correspondence | 1 |
| 04/06/2019 | General Document | 49 |
| 24/12/2019 | Outgoing Correspondence | 1 |